Kanagawa, Japan

Takayuki Oe

This inventor holds 2 USPTO granted patents. Top assignee: Mitsubishi Chemical Corporation. Active years: 1997-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takayuki Oe. Retrieved from https://idiyas.com/inventor/takayuki-oe-9ftvnedv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 69(Granted Patents)


Location History:

  • Yokohama, JP (1997)
  • Kanagawa, JP (2003)

Company Filing History:


Years Active: 1997-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Takayuki Oe

Introduction

Takayuki Oe is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. With a total of 2 patents, Oe's work focuses on innovative solutions that enhance drug stability and efficacy.

Latest Patents

Oe's latest patents include the invention of type A crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione. This invention is characterized by its unique absorption peaks in a powder X-ray diffraction pattern, which contribute to its stability and advantages in pharmaceutical preparation. Additionally, he has developed naphthalene derivatives that are useful for reducing blood sugar and blood lipid levels, showcasing his commitment to addressing critical health issues.

Career Highlights

Oe is currently employed at Mitsubishi Chemical Corporation, where he continues to innovate and contribute to the field of chemical research. His work has garnered attention for its practical applications in medicine and health.

Collaborations

Some of his notable coworkers include Hiroaki Ueno and Ichiro Suehiro, with whom he collaborates on various research projects.

Conclusion

Takayuki Oe's contributions to the field of chemistry and pharmaceuticals highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to advancing scientific knowledge and practical applications in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…